Delivery Order SPE2DB24D1205-SPE2DB25FCZZS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Estrace 0.01% Cream in a 42.5-gram quantity. This firm fixed-price delivery order, valued at $5,201.20, represents a non-competitive set-aside procurement and is scheduled for completion by July 23, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,418.19 to AmerisourceBergen Drug Corp for Estrace 0.01% cream (42.5 grams) on August 27, 2025, with completion targeted for August 28, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's status as a child contract under the company's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,407.76 to AmerisourceBergen Drug Corp for Estrace 0.01% Cream in a 42.5-gram quantity. This contract, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was made competitively and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Estradiol 0.01% Cream in 42.5 gram quantities. This firm fixed-price delivery order, valued at $1,255.56, represents a non-competitive set-aside transaction and is scheduled for completion by August 26, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Estrace 0.01% Cream in a 42.5-gram formulation, valued at $1,145.09. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Estradiol 0.01% Cream (42.5GM) on July 22, 2025, with a ceiling value of $1,150.32 and an ultimate completion date of July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,823.84, is for the delivery of Estrace 0.01% Cream, a pharmaceutical product used in medical care. The order has a performance period through July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, to provide Estrace 0.01% cream. The contract is a firm fixed price delivery order with a ceiling value of $1,736.50 and a period of performance through March 20, 2024. Amerisourcebergen Drug Corp. is the prime contractor for this award, which does not have a set-aside designation. The contract is a part of...
- This $2,048.36 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of Estrace 0.01% Cream, a prescription pharmaceutical product, to support the medical needs of U.S. government agencies and healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $140,000 to Amerisourcebergen Drug Corporation for the supply of Estrace 0.01% cream. As the prime contractor, Amerisourcebergen will deliver 42.5 grams of the specified medication to its place of performance in Conshohocken, Pennsylvania by the end date of August 29, 2023. The Defense Logistics Agency is the Department of Defense's combat logistics support agency, responsible for worldwide logistics...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZZSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Estrace 0.01% Cream in 42.5-gram units, with a ceiling value of $2,357.79 and an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters and primary operations as a major pharmaceutical distributor serving federal medical procurement needs. AmerisourceBergen Drug Corp holds a significant $999.9 billion prime indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX) running through December 2026, which serves as the overarching contract vehicle enabling delivery orders such as this one. As a critical vendor for military and veteran healthcare systems, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers globally. This delivery order for hormone treatment medication exemplifies the company's role in fulfilling ongoing federal medical supply requirements through a flexible contracting mechanism that streamlines procurement processes for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/29/25 |